INFECTIOUS MONONUCLEOSIS AT CHILDREN: FEATURES OF THE COURSE OF THE DISEASE DEPENDING ON TYPES OF ANTIVIRAL THERAPY

Purpose: The article contains results of the comparative analysis of dynamics of immunological parameters in the clinical period at children with an infectious mononucleosis of moderate severity during the acute period at treatment by the drugs “Anaferon kids “ and “Viferon” and further, in a catamn...

Full description

Saved in:
Bibliographic Details
Main Authors: Z. A. Khokhlova, O. A. Popova, K. I. Chujkova, V. L. Yakimov, Yu. V. Minakova, E. I. Petrova
Format: Article
Language:Russian
Published: Journal Infectology 2017-10-01
Series:Журнал инфектологии
Subjects:
Online Access:https://journal.niidi.ru/jofin/article/view/635
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849241140757266432
author Z. A. Khokhlova
O. A. Popova
K. I. Chujkova
V. L. Yakimov
Yu. V. Minakova
E. I. Petrova
author_facet Z. A. Khokhlova
O. A. Popova
K. I. Chujkova
V. L. Yakimov
Yu. V. Minakova
E. I. Petrova
author_sort Z. A. Khokhlova
collection DOAJ
description Purpose: The article contains results of the comparative analysis of dynamics of immunological parameters in the clinical period at children with an infectious mononucleosis of moderate severity during the acute period at treatment by the drugs “Anaferon kids “ and “Viferon” and further, in a catamnesis, within 6 years. The materials and methods: In group of research was 187 children. Three groups were created: the I group (n=75) – the patients receiving during the acute period «Anaferon kids» and pathogenetic therapy, the II group (n=72) – «Viferon» and pathogenetic therapy, the III group (n=40) – only with pathogenetic therapy. Results: Against the background of therapy with «Anaferon kids» and «Viferon» normalization of clinical symptoms and laboratory indicators came quicker in comparison with group of the children receiving only symptomatic therapy. At observation in a catamnesis, at all children the high rate of recurrent respiratory diseases was noted by viral infections. Changes in immunologic indicators became perceptible in all three groups throughout the entire period of observation.
format Article
id doaj-art-cb1264e7aa6945b7b673716d5d9f5f25
institution Kabale University
issn 2072-6732
language Russian
publishDate 2017-10-01
publisher Journal Infectology
record_format Article
series Журнал инфектологии
spelling doaj-art-cb1264e7aa6945b7b673716d5d9f5f252025-08-20T04:00:15ZrusJournal InfectologyЖурнал инфектологии2072-67322017-10-0193677410.22625/2072-6732-2017-9-3-67-74578INFECTIOUS MONONUCLEOSIS AT CHILDREN: FEATURES OF THE COURSE OF THE DISEASE DEPENDING ON TYPES OF ANTIVIRAL THERAPYZ. A. Khokhlova0O. A. Popova1K. I. Chujkova2V. L. Yakimov3Yu. V. Minakova4E. I. Petrova5Novokuznetsk State Institute for Further Training of Physicians – Branch Campus of Russian Medical Academy of Continuous Professional EducationGazprom Transgaz Tomsk LTdGazprom Transgaz Tomsk LTd, medical health center «Kedrovyj» LPUMGSiberian State Medical UniversitySiberian State Medical UniversitySiberian State Medical UniversitySiberian State Medical UniversityPurpose: The article contains results of the comparative analysis of dynamics of immunological parameters in the clinical period at children with an infectious mononucleosis of moderate severity during the acute period at treatment by the drugs “Anaferon kids “ and “Viferon” and further, in a catamnesis, within 6 years. The materials and methods: In group of research was 187 children. Three groups were created: the I group (n=75) – the patients receiving during the acute period «Anaferon kids» and pathogenetic therapy, the II group (n=72) – «Viferon» and pathogenetic therapy, the III group (n=40) – only with pathogenetic therapy. Results: Against the background of therapy with «Anaferon kids» and «Viferon» normalization of clinical symptoms and laboratory indicators came quicker in comparison with group of the children receiving only symptomatic therapy. At observation in a catamnesis, at all children the high rate of recurrent respiratory diseases was noted by viral infections. Changes in immunologic indicators became perceptible in all three groups throughout the entire period of observation.https://journal.niidi.ru/jofin/article/view/635infectious mononucleosisclinical pictureimmunologycatamnesis
spellingShingle Z. A. Khokhlova
O. A. Popova
K. I. Chujkova
V. L. Yakimov
Yu. V. Minakova
E. I. Petrova
INFECTIOUS MONONUCLEOSIS AT CHILDREN: FEATURES OF THE COURSE OF THE DISEASE DEPENDING ON TYPES OF ANTIVIRAL THERAPY
Журнал инфектологии
infectious mononucleosis
clinical picture
immunology
catamnesis
title INFECTIOUS MONONUCLEOSIS AT CHILDREN: FEATURES OF THE COURSE OF THE DISEASE DEPENDING ON TYPES OF ANTIVIRAL THERAPY
title_full INFECTIOUS MONONUCLEOSIS AT CHILDREN: FEATURES OF THE COURSE OF THE DISEASE DEPENDING ON TYPES OF ANTIVIRAL THERAPY
title_fullStr INFECTIOUS MONONUCLEOSIS AT CHILDREN: FEATURES OF THE COURSE OF THE DISEASE DEPENDING ON TYPES OF ANTIVIRAL THERAPY
title_full_unstemmed INFECTIOUS MONONUCLEOSIS AT CHILDREN: FEATURES OF THE COURSE OF THE DISEASE DEPENDING ON TYPES OF ANTIVIRAL THERAPY
title_short INFECTIOUS MONONUCLEOSIS AT CHILDREN: FEATURES OF THE COURSE OF THE DISEASE DEPENDING ON TYPES OF ANTIVIRAL THERAPY
title_sort infectious mononucleosis at children features of the course of the disease depending on types of antiviral therapy
topic infectious mononucleosis
clinical picture
immunology
catamnesis
url https://journal.niidi.ru/jofin/article/view/635
work_keys_str_mv AT zakhokhlova infectiousmononucleosisatchildrenfeaturesofthecourseofthediseasedependingontypesofantiviraltherapy
AT oapopova infectiousmononucleosisatchildrenfeaturesofthecourseofthediseasedependingontypesofantiviraltherapy
AT kichujkova infectiousmononucleosisatchildrenfeaturesofthecourseofthediseasedependingontypesofantiviraltherapy
AT vlyakimov infectiousmononucleosisatchildrenfeaturesofthecourseofthediseasedependingontypesofantiviraltherapy
AT yuvminakova infectiousmononucleosisatchildrenfeaturesofthecourseofthediseasedependingontypesofantiviraltherapy
AT eipetrova infectiousmononucleosisatchildrenfeaturesofthecourseofthediseasedependingontypesofantiviraltherapy